Dysregulation in both C1q and CD47 have been implicated in age-related diseases such as Multiple Sclerosis (MS), a chronic demyelinating disease (32, 33), synapse removal (34, 35), and normal aging (36). Here, CD47 is linked to myeloid sarcoma.